Risks of leukaemia and solid tumours in individuals with Down's syndrome

Lancet

Volumn 355, Issue 9199, 2000, Pages 165-169

  Hasle, Henrik ^a   Haunstrup Clemmensen, Inge ^b   Mikkelsen, Margareta ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; DENMARK; DOWN SYNDROME; FEMALE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0342905433     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05264-2     Document Type: Article

References (41)

1. Krivit W., Good R.A. Simultaneous occurrence of mongolism and leukemia. Am J Dis Child. 94:1957;289-298.
2. Fong C.T., Brodeur G.M. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet. 28:1987;55-76.
3. Iselius L., Jacobs O., Morton N. Leukaemia and transient leukaemia in Down syndrome. Hum Genet. 85:1990;477-485.
4. Bain B. Down's syndrome-transient abnormal myelopoiesis and acute leukemia. Leuk Lymphoma. 3:1991;309-317.
5. Zipursky A., Poon A., Doyle J. Leukemia in Down syndrome: a review. Leuk Res. 9:1992;139-149.
6. Avet Loiseau H., Mechinaud F., Harousseau J.L. Clonal hematologic disorders in Down syndrome: a review. J Pediatr Hematol Oncol. 17:1995;19-24.
7. Robinson L.L., Nesbit M.E.J., Sather H.N.et al. Down syndrome and acute leukemia in children; a 10-year retrospective survey from Children's Cancer Study Group. J Pediatr. 105:1984;235-242.
8. Hasle H., Kerndrup G., Jacobsen B.B. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia. 9:1995;1569-1572.
9. Zipursky A., Thorner P., De Harven E., Christensen H., Doyle J. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Leuk Res. 18:1994;163-171.
10. Bentley D. A case of Down's syndrome complicated by retinoblastoma and celiac disease. Pediatrics. 56:1975;131-133.
11. Windham G.C., Bjerkedal T., Langmark F. A population-based study of cancer incidence in twins and in children with congenital malformations or low birth weight, Norway, 1967-1980. Am J Epidemiol. 121:1985;49-56.
12. Satgé D., Le Tourneau A., Verger J.P.et al. A case report of Down syndrome and centroblastic lymphoma. Pathol Res Pract. 192:1996;1266-1269.
13. Narod S.A., Stiller C.A., Lenoir G.M. An estimate of the heritable fraction of childhood cancer. Br J Cancer. 63:1991;993-999.
14. Satgé D., Sasco A.J., Cure H., Leduc B., Sommelet D., Vekemans M.J. An excess of testicular germ cell tumours in Down's syndrome: three case reports and a review of the literature. Cancer. 80:1997;929-935.
15. Satgé D., Sasco A.J., Carlsen N.L.T.et al. A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res. 58:1998;448-452.
16. Olson J.M., Hamilton A., Breslow N.E. Non-11p constitutional chromosome abnormalities in Wilms' tumour patients. Med Pediatr Oncol. 24:1995;305-309.
17. Satgé D., Sommelet D., Geneix A., Nishi M., Malet P., Vekemans M. A tumoral profile in Down's syndrome. Am J Med Genet. 78:1998;207-216.
18. Hasle H., Mellemgraad A., Nielsen J., Hansen J. Cancer incidence in men with Klinefelter syndrome. Br J Cancer. 71:1995;416-420.
19. Hasle H., Olsen J.H., Nielsen J., Hansen J., Friedrich U., Tommerup N. Occurrence of cancer in women with Turner syndrome. Br J Cancer. 73:1996;1156-1159.
20. Storm H.H., Michelsen E.V., Clemmensen I.H., Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull. 44:1997;549-553.
21. Slørdahl S.H., Smeland E.B., Holte H., Grønn M., Lie S.O., Sip M. Leukemic blasts with markers of four cell lineages in Down's syndrome ("Megakaryoblastic leukemia"). Med Pediatr Oncol. 21:1993;254-258.
22. Shen J.J., Williams B.J., Zipursky A.et al. Cytogenetic and molecular studies of Down syndrome individuals with leukaemia. Am J Hum Genet. 56:1995;915-925.
23. Fester A., Verhest A., Vamos E., De Maertelaere E., Otten J. Leukemia in a trisomy 21 mosaic: specific involvement of the trisomic cells. Cancer Genet Cytogenet. 20:1986;109-113.
24. Simon J.H., Tebbi C.K., Freeman A.I., Brecher M.L., Green D.M., Sandberg A.A. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome. Cancer. 60:1987;2515-2520.
25. Hayashi Y., Eguchi M., Sugita K.et al. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood. 72:1988;15-23.
26. Okuda T., Cai Z., Yang S.et al. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generated dysplastic hematopoietic progenitors. Blood. 91:1998;3134-3143.
27. Ho C.Y., Otterud B., Legare R.D.et al. Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.1. Blood. 87:1996;5218-5224.
28. Ives J.H., Dagna-Bricarelli F., Basso G.et al. Increased levels of a chromosome 21-encoded tumour invasion and metastatic factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML. Genes Chromosomes Cancer. 23:1998;61-66.
29. Chik K., Li C., Shing M.M., Leung T., Yuen P.M. Intracranial germ cell tumours in children with and without Down syndrome. J Pediatr Hematol Oncol. 21:1999;149-151.
30. Fabia J., Drolette M. Malformations and leukaemia in children with Down's syndrome. Pediatrics. 45:1970;60-70.
31. Øster J., Mikkelsen M., Nielsen A. Mortality and life-table in Down's syndrome. Acta Paediatr Scand. 64:1975;322-326.
32. Balarajan R., Donnan S.P.B., Adelstein A.M. Mortality and cause of death in Down's syndrome. J Epidemiol Community Health. 36:1982;127-129.
33. Scholl T., Stein Z., Hansen H. Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1986. Dev Med Child Neurol. 24:1982;817-829.
34. Salo M.K., Solakivi-Jaakkola T., Kivimäki T., Nikkari T Plasma lipids and lipoproteins in Down's syndrome. Scand J Clin Invest. 39:1979;485-490.
35. Schupf N., Zigman W., Kappell D., Lee J.H., Kline J., Levin G. Early menopause in women with Down's syndrome. J Intellect Disabil Res. 41:1997;264-267.
36. De La Torre R., Casado A., Lopez-Fernández E., Carrascosa D., Ramirez V., Saez J. Overexpression of copper-zinc superoxide dismutase in trisomy 21. Experientia. 52:1996;871-873.
37. Sakata K., Tamura G., Nishizuka S.et al. Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach. Genes Chromosomes Cancer. 18:1997;318-321.
38. Bravard A., Sabatier L., Hoffschir F., Ricoul M., Luccioni C., Dutrillaux B. SOD 2: a new type of tumor-suppressor gene? Int J Cancer. 51:1992;476-480.
39. Kohno T., Kawanishi M., Matsuda S.et al. Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma. Genes Chromosomes Cancer. 21:1998;236-243.
40. Busciglio J., Yanker B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
41. Gericke G.S., Hesseling P.B., Brink S., Tiedt F.C. Leucocyte ultrastructure and folate metabolism in Down's syndrome. S Afr Med J. 51:1977;369-374.